Invention Grant
- Patent Title: Specific HCV NS3 protease inhibitors
- Patent Title (中): 特异性HCV NS3蛋白酶抑制剂
-
Application No.: US13284641Application Date: 2011-10-28
-
Publication No.: US08729014B2Publication Date: 2014-05-20
- Inventor: Jerome Courcambeck , Philippe Halfon , Mourad Bouzidi , Steven J. Coats , Richard Anthony Whitaker
- Applicant: Jerome Courcambeck , Philippe Halfon , Mourad Bouzidi , Steven J. Coats , Richard Anthony Whitaker
- Applicant Address: US GA Tucker FR Marseille
- Assignee: RFS Pharma, LLC,Genoscience
- Current Assignee: RFS Pharma, LLC,Genoscience
- Current Assignee Address: US GA Tucker FR Marseille
- Agency: Hultquist, PLLC
- Agent Steven J. Hultquist; David Bradin
- Main IPC: A61K38/06
- IPC: A61K38/06 ; C07K5/083
Abstract:
The present invention is directed to compounds, compositions and methods for treating or preventing viral infections, in particular, HCV in human patients or other animal hosts.
Public/Granted literature
- US20120129765A1 NOVEL SPECIFIC HCV NS3 PROTEASE INHIBITORS Public/Granted day:2012-05-24
Information query
IPC分类:
